2023-503949-65-00已完成1 期
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participants
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission Hub
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in healthy female participants of childbearing potential.2023-505297-15-00Abivax, Abivax36
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
已完成
1 期
A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin.Heart Failure2024-514431-18-00Novo Nordisk A/S56